MOLM-13  Xenografts

 

 

Rincon Bio performs MOLM-13 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Leukemia/

Lymphoma

MOLM-13 were derived from the peripheral blood of a patient with acute monocytic leukemia

Notes

Oncogene: myc +

Genes expressed: tumor necrosis factor (TNF) after stimulation with phorbol myristic acid, myc +. Ref

in vivo

Used in xenografts to test the efficacy of novel cancer therapeutics.  Tumors develop after being injected into the flank of immunocompromised mice. 

Request Quote

Receive a quote within one business day for a MOM-13 Xenograft

Rincon Bio Growth Curve

molm13.png

Cell Line: MOLM-13 

Mouse Strain: Athymic nude Fox1nu [Hsd] (Envigo, Cat. 6902) 

Animals per Group: 10 

Positive Control: N/A 

Concentration: N/A 

Matrigel: Yes 

Dosing schedule: N/A 

Stratification size: 200mm^3 

Days from implant to stratification: 10 

Cells Implanted per Animal: 10 million

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are flexible and easy to work with.  And we take a personal interest in our clients' studies.